Publication:
The Effect of Synthetic Cannabinoids on P-Wave Dispersion: An Observational Study

dc.contributor.authorSÜNBÜL, MURAT
dc.contributor.authorsSunbul, Esra Aydin; Sunbul, Murat; Terzi, Ayse; Calli, Sumeyye; Koca, Esra; Bilici, Rabia; Citak, Serhat
dc.date.accessioned2022-03-14T08:16:00Z
dc.date.accessioned2026-01-10T21:21:44Z
dc.date.available2022-03-14T08:16:00Z
dc.date.issued2016
dc.description.abstractObjective: The aim of this study was to investigate the effect of synthetic cannabinoids (SC) on P-wave dispersion (PD) in patients who consume SC. Materials and Methods: The study population included 72 patients who consumed SC and 36 age-and sex-matched healthy controls. The severity of addiction was detected using the addiction profile index (BAPI). The PD was measured by 12-lead ECG obtained upon admission to hospital. Statistical analyses were performed using the SPSS v20.0 statistical software package. Results: The mean age of the patients and controls was 26.9 +/- 7.0 and 26.3 +/- 6.5 years, respectively. Mean duration of SC consumption was 1.7 +/- 0.7 years. Mean BAPI score of patients who consumed SC was 12.8 +/- 3.4. Patients who consumed SC had a significantly higher PD value than controls (37.7 +/- 11.5 vs. 30.6 +/- 6.4 ms, p < 0.001). The BAPI score was significantly correlated with PD value (r = 0.675, p < 0.001). In the linear regression model that included PD value, age and heart rate, PD value was significantly and independently correlated with BAPI score (r(2) of the model = 0.339; p < 0.001). Conclusions: In this study, patients who consumed SC had significantly higher PD values than controls, and the BAPI score correlated with the PD value. Hence SC consumption could lead to an increased risk of cardiovascular disease through prolonged PD. We recommend the use of the simple and inexpensive ECG to assess cardiovascular risk in patients who consume SC. (C) 2016 S. Karger AG, Basel.
dc.identifier.doi10.1159/000447516
dc.identifier.eissn1423-0151
dc.identifier.issn1011-7571
dc.identifier.pubmed27287436
dc.identifier.urihttps://hdl.handle.net/11424/241347
dc.identifier.wosWOS:000383904000014
dc.language.isoeng
dc.publisherKARGER
dc.relation.ispartofMEDICAL PRINCIPLES AND PRACTICE
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCardiovascular risk
dc.subjectP-wave dispersion
dc.subjectSynthetic cannabinoids
dc.subjectCORONARY-ARTERY-DISEASE
dc.subjectHYPERTENSIVE PATIENTS
dc.subjectATRIAL-FIBRILLATION
dc.subjectNON-DIPPER
dc.subjectDEPRESSION
dc.subjectASSOCIATION
dc.subjectDYSFUNCTION
dc.subjectPREDICTOR
dc.subjectDISORDER
dc.subjectDURATION
dc.titleThe Effect of Synthetic Cannabinoids on P-Wave Dispersion: An Observational Study
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage487
oaire.citation.issue5
oaire.citation.startPage483
oaire.citation.titleMEDICAL PRINCIPLES AND PRACTICE
oaire.citation.volume25

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
458.1 KB
Format:
Adobe Portable Document Format